What is behind the disagreement over COVID-19 vaccine waiver?

Almost everyone agrees one way to beat the pandemic is to increase global vaccine production.
But world leaders differ on how to give more access to poor nations that lack doses.
The US has supported suspending intellectual property rights on vaccines.
That could allow developing nations to acquire the knowledge needed to produce jabs locally.
But some European leaders argue a patent waiver would not help boost supply.
They insist making and sharing vaccines more quickly is the best way to do that.
Is this politically motivated?
And what does it mean for millions of people waiting to get their shots?

Presenter: Hashem Ahelbarra

Guests
Jeffrey Lazarus, Head of the Health Systems Research Group at Barcelona Institute for Global Health.
Rajeshwari Hariharan, Intellectual Property Lawyer.
Azeddine Ibrahimi, Director of the Medical Biotechnology Laboratory at Rabat Medical and Pharmacy School.

- Subscribe to our channel: http://aje.io/AJSubscribe
- Follow us on Twitter: https://twitter.com/AJEnglish
- Find us on Facebook: https://www.facebook.com/aljazeera
- Check our website: https://www.aljazeera.com/

#COVID19VaccinePatentWaiver #COVID19 #InsideStory